Using lipid nanoparticles (LNPs), NMIN research leaders Drs. Pieter Cullis and Christian Kastrup, together with colleagues at The University of British Columbia (UBC), have developed a new tool that can… Read More »NMIN researchers: A new nanomedicine treatment for thrombosis?
In a new review article published in Advanced Drug Delivery Reviews, NMIN researchers and colleagues discuss the use of state-of-the-art lipid nanoparticle (LNP) technology for therapeutic gene regulation in the… Read More »Lipid nanoparticle technology: poised to have a revolutionary impact
On March 31, 2020, NMIN’s Board of Directors approved a second round of research investment, supporting nine new projects—two within each of NMIN’s Research Themes (Targeted Drug Delivery, Gene Therapy,… Read More »Update: NMIN makes nine new research investments
NMIN Research Leader Dr. Shana Kelley discusses how new rapid diagnostic technologies could transform the way the COVID-19 pandemic is managed, in a webinar recorded on July 7, 2020. https://youtu.be/Zj4-N_CyuRg… Read More »NMIN research leader discusses new diagnostic technology as key to “pandexit”
As of July 13, 2020, NMIN has a new Manager of Research and Partnerships: April O’Connell, BA, CHRP, CHRL. April brings eight years’ experience managing a multimillion-dollar research portfolio for… Read More »Meet April O’Connell, NMIN’s new Manager, Research & Partnerships
Two NMIN researchers based at the University of British Columbia (UBC) have been awarded CIHR funding to support projects addressing COVID19-related health challenges. NMIN’s Scientific Director, Dr. Pieter Cullis, was… Read More »NMIN researchers awarded CIHR funding for COVID-19 projects
The NanoMedicines Innovation Network (NMIN) is pleased to welcome the following new members to its Board of Directors (L to R above): Vanessa Grant, Partner, Norton Rose Fulbright Canada LLP… Read More »NMIN welcomes three new Board members
NMIN research co-leader Dr. Christan Kastrup and his research team find that soil silicates play a key role in blood clotting Research led by Dr. Christian Kastrup and published in… Read More »Soil stops bleeding: NMIN researcher
NMIN has granted Strategic Initiative funding to kick-start an effort to develop nanomedicines to fight COVID-19. NMIN’s Scientific Director Dr. Pieter Cullis leads this initiative, which is exploring the use… Read More »NMIN seed-funds COVID-19 therapeutics project
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to… Read More »The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director